Toei Shinyaku Files Patent for King Agaricus KA21 for Improving Male Menopausal Symptoms such as ED and Hair Loss
Expected Applications in Hair Growth, Menopausal Disorders, and ED Recovery Supplements for Men
Toei Shinyaku Co.,ltd.
Toei Shinyaku Co., Ltd. (Headquarters: Mitaka, Tokyo; CEO: Akitomo Motoi) conducted a joint study with Shigakkan University’s Faculty of Health Sciences on our outdoor-cultivated Agaricus blazei/brasiliensis/subrufescens KA21 strain (hereinafter referred to as King Agaricus KA21). The study confirmed the improvement effects of King Agaricus KA21 intake on male menopausal symptoms such as ED and hair loss. Based on these findings, we are pleased to report that we have filed a patent for "Compositions for Improving Male Menopausal Symptoms such as Hair Loss and ED, and Pharmaceuticals and Food Products Containing These."
Overview
Patent Application Number: 2024-109541
Submission Date: July 8, 2024
Inventors: Hirobumi Tada, Akitomo Motoi
Patent Applicants: Toei Shinyaku Co., Ltd., Shigakkan University
Title of the Invention:
"Compositions for Improving Male Menopausal Symptoms such as ED and Hair loss, and Pharmaceuticals and Food Products Containing These."
Technical Field:
This invention relates to compositions for improving male menopausal symptoms such as ED and hair loss, and pharmaceuticals and food products containing these.
Study Data
24 men aged 50 to 70 were given 900mg of outdoor-cultivated Agaricus KA21 daily for two months, and the indicators related to male menopausal symptoms were compared before and after intake. Significant improvements were observed in AMS (Aging Males Symptoms) scores, indicators for assessing male menopausal symptoms including mental, psychological, and physical aspects, EHS (Erection Hardness) scores for evaluating ED, SHIM (Sexual Health Inventory for Men) scores for male sexual health assessment, and hair loss conditions.
*P < 0.05, ***P < 0.001
About Male Menopausal Symptoms
Testosterone, a male hormone, plays a crucial role in maintaining male physical and mental functions. However, the amount of testosterone gradually decreases with age. External factors such as lifestyle and stress also impact testosterone levels. Decreased testosterone is closely related to conditions such as sarcopenia, which involves muscle loss and muscle weakness, and also affects the causes and prevention of various diseases, including angina, arteriosclerosis, obesity, metabolic syndrome, and dementia. These conditions associated with decreased testosterone are known as Late Onset Hypogonadism (LOH) syndrome. Reports indicate that about 10% of middle-aged men in employment suffer from male menopausal symptoms, with a notable prevalence starting from the late 40s, making LOH a significant social and economic concern.
LOH manifests in a variety of symptoms including general fatigue, decreased libido, lack of motivation, ED, difficulty concentrating, insomnia, irritability, shoulder stiffness, urination problems, a sense of heaviness in the head, and fewer morning erections. Additionally, age-related testosterone decline increases the risk of several health issues such as depression, sexual dysfunction, cognitive decline, cardiovascular diseases, increased visceral fat, insulin resistance, decreased HDL cholesterol, and elevated total cholesterol and LDL cholesterol.
Excerpt from the Japan Men’s Health Medical Association website
About Agaricus blazei/brasilensis/subrufescens
Agaricus blazei/brasiliensis/subrufescens is a type of mushroom widely used in the field of complementary and alternative medicine as a health food and supplement. The characteristics and components of Agaricus vary depending on the strain, cultivation conditions, and origin. The quality of Agaricus-containing products also varies significantly among different products.
Brazilian Outdoor-Cultivated Agaricus KA21 Strain (King Agaricus KA21)
King Agaricus KA21 is cultivated outdoors under the sun using the King Agaricus 21 strain (KA21) in Brazil. Compared to typical indoor-cultivated Agaricus grown in dark conditions, this strain grows larger and contains more key components such as β-glucan and vitamin D. It also features over five times higher antioxidant activity.
(*1) According to the Japan Food Research Institute
(*2) IntJMedMushrooms.2019033173, pages 31-43
King Agaricus KA21 cultivated outdoor
Size comparison Left: Indoor cultivated / Right: Outdoor cultivated
■About Toei Shinyaku Co., Ltd.
Toei Shinyaku Co., Ltd., the manufacturer of King Agaricus KA21, has been engaged in research and development of the KA21 strain for over 28 years, with 33 international research papers published. The company has collaborated on various studies with institutions such as the School of Veterinary Medicine at Azabu University, the Keio University SFC Research Institute, the National Center for Geriatrics and Gerontology, the School of Medicine at Juntendo University, the Food Safety Research Center at the University of Tokyo, and the Department of Immunology at the Tokyo University of Pharmacy and Life Sciences. Toei Pharmaceuticals has presented various beneficial data on outdoor-cultivated King Agaricus KA21.
Company Name :Toei Shinyaku Co.Ltd.
Head Office: 1-11-23 Shimorenjaku, Mitaka-shi, Tokyo 181-0013
Representative: Akitomo Motoi, President
Capital :10 million yen
- Category:
- Corporate Trends